1. Home
  2. MCRB vs DUOT Comparison

MCRB vs DUOT Comparison

Compare MCRB & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$9.16

Market Cap

139.7M

Sector

Health Care

ML Signal

HOLD

Logo Duos Technologies Group Inc.

DUOT

Duos Technologies Group Inc.

HOLD

Current Price

$7.51

Market Cap

158.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCRB
DUOT
Founded
2010
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
139.7M
158.9M
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
MCRB
DUOT
Price
$9.16
$7.51
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$14.33
$14.00
AVG Volume (30 Days)
43.7K
662.6K
Earning Date
03-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.90
EPS
0.64
N/A
Revenue
$789,000.00
$7,280,885.00
Revenue This Year
N/A
$286.66
Revenue Next Year
N/A
$44.93
P/E Ratio
$12.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$3.84
52 Week High
$29.98
$12.17

Technical Indicators

Market Signals
Indicator
MCRB
DUOT
Relative Strength Index (RSI) 45.79 42.47
Support Level $7.55 $6.99
Resistance Level $9.53 $8.45
Average True Range (ATR) 0.62 0.39
MACD 0.17 0.06
Stochastic Oscillator 71.43 32.72

Price Performance

Historical Comparison
MCRB
DUOT

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Share on Social Networks: